Literature DB >> 32371172

Cell-to-Cell Transmission of Tau and α-Synuclein.

Norihito Uemura1, Maiko T Uemura1, Kelvin C Luk1, Virginia M-Y Lee1, John Q Trojanowski2.   

Abstract

The stereotypical spread of pathological protein inclusions and clinicopathological heterogeneity are well described in neurodegenerative diseases. Accumulating evidence suggests that the former can be attributed to consecutive cell-to-cell transmission of pathological proteins between anatomically connected brain regions, while the latter has been hypothesized to result from the spread of conformationally distinct pathological protein aggregates, or strains. These emerging concepts have dramatically changed our understanding of neurodegenerative diseases. In this review, we first summarize the background and recent findings underpinning these concepts with a focus on two major pathological proteins: tau and α-synuclein. We then discuss their clinical implications for tauopathies and synucleinopathies and propose a working hypothesis for future research.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Parkinson’s disease; propagation; strains; synucleinopathies; tauopathies

Mesh:

Substances:

Year:  2020        PMID: 32371172      PMCID: PMC7529725          DOI: 10.1016/j.molmed.2020.03.012

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  144 in total

1.  In vivo demonstration that alpha-synuclein oligomers are toxic.

Authors:  Beate Winner; Roberto Jappelli; Samir K Maji; Paula A Desplats; Leah Boyer; Stefan Aigner; Claudia Hetzer; Thomas Loher; Marçal Vilar; Silvia Campioni; Christos Tzitzilonis; Alice Soragni; Sebastian Jessberger; Helena Mira; Antonella Consiglio; Emiley Pham; Eliezer Masliah; Fred H Gage; Roland Riek
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-15       Impact factor: 11.205

2.  Propagation of tau misfolding from the outside to the inside of a cell.

Authors:  Bess Frost; Rachel L Jacks; Marc I Diamond
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

3.  Assessment of α-synuclein secretion in mouse and human brain parenchyma.

Authors:  Evangelia Emmanouilidou; Dimitris Elenis; Themis Papasilekas; Georgios Stranjalis; Kyriaki Gerozissis; Penelopi C Ioannou; Kostas Vekrellis
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

4.  Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.

Authors:  Jing L Guo; Sneha Narasimhan; Lakshmi Changolkar; Zhuohao He; Anna Stieber; Bin Zhang; Ronald J Gathagan; Michiyo Iba; Jennifer D McBride; John Q Trojanowski; Virginia M Y Lee
Journal:  J Exp Med       Date:  2016-10-17       Impact factor: 14.307

5.  Extracellular Monomeric and Aggregated Tau Efficiently Enter Human Neurons through Overlapping but Distinct Pathways.

Authors:  Lewis D Evans; Thomas Wassmer; Graham Fraser; James Smith; Michael Perkinton; Andrew Billinton; Frederick J Livesey
Journal:  Cell Rep       Date:  2018-03-27       Impact factor: 9.423

6.  Structures of filaments from Pick's disease reveal a novel tau protein fold.

Authors:  Benjamin Falcon; Wenjuan Zhang; Alexey G Murzin; Garib Murshudov; Holly J Garringer; Ruben Vidal; R Anthony Crowther; Bernardino Ghetti; Sjors H W Scheres; Michel Goedert
Journal:  Nature       Date:  2018-08-29       Impact factor: 49.962

7.  Differential expression of alpha-synuclein in hippocampal neurons.

Authors:  Katsutoshi Taguchi; Yoshihisa Watanabe; Atsushi Tsujimura; Harutsugu Tatebe; Seiji Miyata; Takahiko Tokuda; Toshiki Mizuno; Masaki Tanaka
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

8.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity.

Authors:  Zeshan Ahmed; Jane Cooper; Tracey K Murray; Katya Garn; Emily McNaughton; Hannah Clarke; Samira Parhizkar; Mark A Ward; Annalisa Cavallini; Samuel Jackson; Suchira Bose; Florence Clavaguera; Markus Tolnay; Isabelle Lavenir; Michel Goedert; Michael L Hutton; Michael J O'Neill
Journal:  Acta Neuropathol       Date:  2014-02-16       Impact factor: 17.088

9.  Cryo-EM structures of tau filaments from Alzheimer's disease.

Authors:  Anthony W P Fitzpatrick; Benjamin Falcon; Shaoda He; Alexey G Murzin; Garib Murshudov; Holly J Garringer; R Anthony Crowther; Bernardino Ghetti; Michel Goedert; Sjors H W Scheres
Journal:  Nature       Date:  2017-07-05       Impact factor: 49.962

10.  Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy.

Authors:  Serena Venezia; Violetta Refolo; Alexia Polissidis; Leonidas Stefanis; Gregor K Wenning; Nadia Stefanova
Journal:  Mol Neurodegener       Date:  2017-07-04       Impact factor: 14.195

View more
  28 in total

Review 1.  Neurogenesis in aging and age-related neurodegenerative diseases.

Authors:  Luka Culig; Xixia Chu; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2022-04-29       Impact factor: 11.788

2.  Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala.

Authors:  Liqiang Chen; Chetan Nagaraja; Samuel Daniels; Zoe A Fisk; Rachel Dvorak; Lindsay Meyerdirk; Jennifer A Steiner; Martha L Escobar Galvis; Michael X Henderson; Maxime W C Rousseaux; Patrik Brundin; Hong-Yuan Chu
Journal:  Elife       Date:  2022-07-01       Impact factor: 8.713

3.  Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.

Authors:  Shinya Okuda; Norihito Uemura; Masanori Sawamura; Tomoyuki Taguchi; Masashi Ikuno; Maiko T Uemura; Hodaka Yamakado; Ryosuke Takahashi
Journal:  Neurotherapeutics       Date:  2021-12-21       Impact factor: 6.088

4.  The Origins of the Protein Spread in Parkinson's Disease.

Authors:  Roger A Barker
Journal:  Mov Disord Clin Pract       Date:  2021-08-23

5.  α-Synuclein Propagation Mouse Models of Parkinson's Disease.

Authors:  Norihito Uemura; Jun Ueda; Shinya Okuda; Masanori Sawamura; Ryosuke Takahashi
Journal:  Methods Mol Biol       Date:  2021

Review 6.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

7.  PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding.

Authors:  Alberto Carpinteiro Soares; Andreia Ferreira; Jonas Mariën; Charlotte Delay; Edward Lee; John Q Trojanowski; Dieder Moechars; Wim Annaert; Louis De Muynck
Journal:  J Biol Chem       Date:  2021-04-06       Impact factor: 5.157

8.  A novel tau-based rhesus monkey model of Alzheimer's pathogenesis.

Authors:  Danielle Beckman; Paramita Chakrabarty; Sean Ott; Amanda Dao; Eric Zhou; William G Janssen; Kristine Donis-Cox; Scott Muller; Jeffrey H Kordower; John H Morrison
Journal:  Alzheimers Dement       Date:  2021-03-18       Impact factor: 21.566

9.  α-Synuclein Spread from Olfactory Bulb Causes Hyposmia, Anxiety, and Memory Loss in BAC-SNCA Mice.

Authors:  Norihito Uemura; Jun Ueda; Toru Yoshihara; Masashi Ikuno; Maiko T Uemura; Hodaka Yamakado; Masahide Asano; John Q Trojanowski; Ryosuke Takahashi
Journal:  Mov Disord       Date:  2021-02-06       Impact factor: 9.698

Review 10.  Approaches to Disease Modification for Parkinson's Disease: Clinical Trials and Lessons Learned.

Authors:  Albert Y Hung; Michael A Schwarzschild
Journal:  Neurotherapeutics       Date:  2020-11-17       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.